Updated:
Hyalescent Ventures
Hyalescent Ventures is a Phoenix-based early-stage technology investment firm targeting enterprise software and fintech startups outside coastal venture...
Hyalescent Ventures
Hyalescent Ventures is a Phoenix, AZ-based investment organization focused on healthcare and medical technology. It invests in non-incremental technologies that can significantly change healthcare delivery or patient lives. The firm has made 3 investments, including a Seed VC in Above on July 01, 2019, and has 1 portfolio exit, Beacon Biomedical, on October 31, 2022.
General information
Firm type
Venture Capital
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Phoenix
Corporate office
Phoenix, AZ, United States
Sector focus
Frequently asked questions
What investment stages does Hyalescent Ventures target?
Hyalescent focuses on seed and pre-seed stage investments, typically entering as the first institutional capital after friends-and-family rounds. The firm leads or co-leads rounds and reserves follow-on capital for subsequent funding events through Series A and B. The target initial check size is not publicly disclosed.
How does Hyalescent source its deal flow?
The firm's Phoenix location anchors a sourcing strategy focused on founders building outside traditional coastal venture hubs. Hyalescent cultivates relationships within the Mountain West, Southwest, and Midwest ecosystems, where venture capital density is lower and competitive deal dynamics are less intense. The firm also receives inbound referrals from accelerator networks and regional angel groups.
Which sectors does Hyalescent Ventures prioritize?
Hyalescent invests across enterprise software, fintech, digital health, applied AI, and select industrial technology opportunities. The common thread across portfolio companies is a software-enabled business model solving operational inefficiencies inside large addressable markets. The firm does not actively invest in consumer internet, hardware, or biotechnology.
Does Hyalescent lead rounds or participate as a co-investor?
Hyalescent is willing to lead or co-lead seed rounds and actively negotiates for board observation or information rights. The firm values concentrated ownership positions over widely syndicated cap tables. For follow-on rounds, Hyalescent exercises pro-rata rights where fund economics support continued participation.
How is Hyalescent Ventures structured — is it a fund or a holding company?
Hyalescent operates as a private equity firm, deploying capital through a traditional venture fund structure with limited partners, rather than as a holding company or single-family office. The fund's legal domicile, limited partner composition, and fund size are not publicly disclosed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: